|
ZNF333 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.096200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.355600E-01 |
| Normal-vs-Stage2 |
9.243800E-01 |
| Normal-vs-Stage3 |
1.946130E-02 |
| Normal-vs-Stage4 |
8.883700E-02 |
| Stage1-vs-Stage2 |
5.601200E-01 |
| Stage1-vs-Stage3 |
1.723610E-01 |
| Stage1-vs-Stage4 |
4.429800E-01 |
| Stage2-vs-Stage3 |
2.010400E-01 |
| Stage2-vs-Stage4 |
3.752200E-01 |
| Stage3-vs-Stage4 |
9.038000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.712200E-01 |
| Normal-vs-AfricanAmerican |
6.454600E-01 |
| Normal-vs-Asian |
4.095600E-01 |
| Caucasian-vs-AfricanAmerican |
4.805200E-01 |
| Caucasian-vs-Asian |
8.307800E-01 |
| AfricanAmerican-vs-Asian |
6.859200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.443900E-02 |
| Normal-vs-Female |
4.005000E-01 |
| Male-vs-Female |
5.756900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.254000E-01 |
| Normal-vs-Extreme_Weight |
6.108300E-02 |
| Normal-vs-Obese |
6.254200E-01 |
| Normal-vs-Extreme_Obese |
1.452260E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.262200E-01 |
| Normal_Weight-vs-Obese |
8.572000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.110000E-02 |
| Extreme_Weight-vs-Obese |
1.912350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.264400E-01 |
| Obese-vs-Extreme_Obese |
1.293580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.253200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.774800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.078990E-01 |
| Normal-vs-Age(81-100Yrs) |
4.560800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.366800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.449640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.532300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.033000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.596100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.278620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.947400E-01 |
| Normal-VS-Type2 PRCC |
6.015600E-04 |
| Normal-VS-KIRP CIMP |
2.001800E-01 |
| Normal-VS-Unclassified PRCC |
8.377400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.373800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.220800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.608200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.182200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.601400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.970440E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.059950E-02 |
| Normal-vs-N1 |
2.925800E-01 |
| Normal-vs-N2 |
2.577000E-01 |
| N0-vs-N1 |
4.785600E-01 |
| N0-vs-N2 |
9.522200E-01 |
| N1-vs-N2 |
7.297400E-01 |
|
|
